Refreshing results…
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
UploadShort-course combination treatment for experimental chronic Chagas disease
UploadDNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
UploadPrioritization of Molecular Targets for Antimalarial Drug Discovery
Download from pubs.acs.orgSetting Our Sights on Infectious Diseases
Download from pubs.acs.orgPharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
Download from pubs.acs.orgMissing publications? Search for publications with a matching author name.